Search research articles
Contact Us
Filters
Showing results (81-90 of 197) with videos related to
Page
of 20
Sort By:
Cancer Immunology Research
|
December 19, 2015
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia
Yayoi Shimazu, Yutaka Shimazu, Masakatsu Hishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi, Kei Muro, Hiroshi Ishii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals
Jun Mitsui, Hiroyoshi Nishikawa, Daisuke Muraoka, et al.
ACS Applied Materials & Interfaces
|
May 28, 2024
On-Site Stimulation of Dendritic Cells by Cancer-Derived Extracellular Vesicles on a Core-Shell Nanowire Platform
Min Zhang, Miki Ono, Shota Kawaguchi, et al.
Nature Communications
|
April 7, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell development
Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe, et al.
International Journal of Hematology
|
May 10, 2002
The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors
Masahiro Masuya, Naoyuki Katayama, Natsuki Hoshino, et al.
Blood Advances
|
September 2, 2020
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, et al.
American Journal of Hematology
|
April 1, 2004
Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes
Hirohito Suzuki, Naoyuki Katayama, Yasushi Ikuta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 7, 2022
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Hirotaka Hasegawa, Kohei Shitara, Shuji Takiguchi, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 197) with videos related to
Sort By:
Page
of 20
Cancer Immunology Research
|
December 19, 2015
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia
Yayoi Shimazu, Yutaka Shimazu, Masakatsu Hishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi, Kei Muro, Hiroshi Ishii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals
Jun Mitsui, Hiroyoshi Nishikawa, Daisuke Muraoka, et al.
ACS Applied Materials & Interfaces
|
May 28, 2024
On-Site Stimulation of Dendritic Cells by Cancer-Derived Extracellular Vesicles on a Core-Shell Nanowire Platform
Min Zhang, Miki Ono, Shota Kawaguchi, et al.
Nature Communications
|
April 7, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell development
Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe, et al.
International Journal of Hematology
|
May 10, 2002
The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors
Masahiro Masuya, Naoyuki Katayama, Natsuki Hoshino, et al.
Blood Advances
|
September 2, 2020
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, et al.
American Journal of Hematology
|
April 1, 2004
Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes
Hirohito Suzuki, Naoyuki Katayama, Yasushi Ikuta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 7, 2022
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Hirotaka Hasegawa, Kohei Shitara, Shuji Takiguchi, et al.
Page
of 20